Skip to content

Prospective Evaluating hepatic fibrosis related to HBV using Non-invasive methods

Prospective Evaluating hepatic fibrosis related to HBV using Non-invasive methods

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13003724
Enrollment
Unknown
Registered
2013-10-01
Start date
2013-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic infection with Hepatitis B virus

Interventions

Gold Standard:
Index test:

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female aged 18 to 65 years old; 2. HBsAg positive for 6 months; 3. agree to have liver biopsy

Exclusion criteria

Exclusion criteria: 1. Patients with alcoholic liver disease, autoimmune liver disease, heretic liver disease, drug induced liver disease, nonalcoholic liver disease or other chronic liver disease; 2. PLT <80×10^9/L; 3. PTA <=60%; 4. patients with any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject.

Design outcomes

Primary

MeasureTime frame
liver biopsy;serum parameters;radiological parameters;fibroscan test;

Contacts

Public ContactGui-Qiang Wang

Department of Infectious Diseases, Peking University First Hospital

john131212@hotmail.com+86 13911405123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026